Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Musculoskeletal, Other Clinical Trial
Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion
Status: Enrolling, Phase IV
Updated: 1/22/2018
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Osteoarthritis, Knee Clinical Trial
A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System
Status: Enrolling, Phase
Updated: 12/31/1969
Mansfield Orthopaedics
1387
mi
from
Morrisville, VT
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Martin Foot and Ankle
1143
mi
from
York, PA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
Status: Enrolling, Phase
Updated: 12/31/1969
University of Illinois Hospital & Health Sciences System
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Soft Tissue Sarcoma Clinical Trial
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Covenant Children's Hospital
367
mi
from
Lubbock, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Jude Children's Research Hospital
468
mi
from
Memphis, TN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Philadelphia
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Naval Medical Center - San Diego
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Medical College
1299
mi
from
Valhalla, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mission Hospital-Memorial Campus
857
mi
from
Asheville, NC
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dayton Children's Hospital
748
mi
from
Dayton, OH
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
1310
mi
from
Hollywood, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Riley Hospital for Children
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Vincent Hospital and Health Care Center
642
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Summerlin Hospital Medical Center
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Loyola University Medical Center
600
mi
from
Maywood, IL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cardon Children's Medical Center
844
mi
from
Mesa, AZ
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Miller School of Medicine-Sylvester Cancer Center
1320
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Wisconsin
630
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Healthy Volunteers Clinical Trial
Study of Skin Cells That Stop Replicating (Senescent) During Wound Healing
Status: Enrolling, Phase
Updated: 12/31/1969
National Institute of Aging, Clinical Research Unit
1151
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Status: Enrolling, Phase
Updated: 12/31/1969
University of Chicago Medicine
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Status: Enrolling, Phase
Updated: 12/31/1969
Inland Empire Liver Foundation
1120
mi
from
Rialto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
Status: Enrolling, Phase I
Updated: 4/20/2017
National Institutes of Health Clinical Center
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non-Small Cell Lung Carcinoma Clinical Trial
Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.
Status: Enrolling
Updated: 4/20/2017
Advocate Lutheran General Hospital
605
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital of Pittsburgh
973
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Oncology Clinical Trial
Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Participants With Metastatic Uveal Melanoma
Status: Enrolling, Phase I
Updated: 12/31/1969
M D Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Borderline Personality Disorder Clinical Trial
Dialectical Behavior Therapy Rutgers University Research Program
Status: Enrolling
Updated: 12/31/1969
Rutgers University
1265
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Vermont
1356
mi
from
Burlington, VT
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Colorado
404
mi
from
Aurora, CO
Click here to add this to my saved trials
Arthroplasty, Replacement, Hip Clinical Trial
Longjohn Amgen Study - Effect of Denosumab...
Status: Enrolling, Phase I
Updated: 4/24/2017
Keck Medicine of USC
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Oklahoma
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
US Oncology - Texas Oncology Austin, Site #172
517
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Kansas Cancer Center
193
mi
from
Fairway, KS
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
US Oncology - Texas Oncology, PA - Fort Worth
346
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic Florida
1066
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
Arkansas Site Management Services, LLC
371
mi
from
Little Rock, AR
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
UCLA Cardiovascular Center
1179
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mt Sinai Hospital
1290
mi
from
New York, NY
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Heart & Vascular Institute
1378
mi
from
Portland, OR
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic Rochester
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
Stony Brook University Medical Center
1358
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tallahassee Research Institute
925
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
ProMedica Toledo Hospital
804
mi
from
Toledo, OH
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Wyoming Valley Medical Center
1191
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical City Dallas Hospital
339
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory University Hospital
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
The Hartford Hospital
1358
mi
from
Hartford, CT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital
477
mi
from
Memphis, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Sentara Cardiovascular Research Institute
1181
mi
from
Norfolk, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Pennsylvania Hospital
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Banner University Medical Center
851
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
The PARTNER 3 - AVIV Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Allegheny General Hospital
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Clinical Trial
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ of Rochester Medical Center
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Clinical Trial
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
Long Island Jewish Medical Center
1303
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Clinical Trial
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
Stony Brook University Hospital
1358
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Rheumatology, Orthopedics / Podiatry Clinical Trial
Persona Partial Knee Clinical Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Henry County Orthopedics and Sports Medicine
686
mi
from
New Castle, IN
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Nephrology / Urology Clinical Trial
Treatment of Incontinence Associated Dermatitis - Automated
Status: Enrolling
Updated: 12/31/1969
Skyline Urology
1179
mi
from
Torrance, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
1060
mi
from
Buffalo, NY
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
1155
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Spinal Cord Injuries Clinical Trial
Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Brooks Rehabilitation
1060
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)
Status: Enrolling, Phase I
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Ovarian Epithelial Cancer Clinical Trial
Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Columbia University Medical Center
1286
mi
from
New York, NY
Click here to add this to my saved trials
Bronchoscopy Clinical Trial
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy
Status: Enrolling
Updated: 12/31/1969
Stanford Hospital and Clinics
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Dell Children's Medical Center of Central Texas
514
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Alabama
684
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Vermont College of Medicine
1356
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Blank Children's Hospital
346
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Helen DeVos Children's Hospital at Spectrum Health
733
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Children's Medical Center
1358
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
C S Mott Children's Hospital
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Healthcare of Atlanta - Egleston
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Foundation
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hackensack University Medical Center
1285
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa - Holden Comprehensive Cancer Center
429
mi
from
Iowa City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Nemours Children's Clinic - Jacksonville
1058
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Children's Hospital
1219
mi
from
Madera, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
574
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale University
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Columbia University Herbert Irving Cancer Center
1290
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of San Antonio
577
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
1201
mi
from
Spokane, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Childrens National Medical Center
1127
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Hospital
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Carcinoma, Non Small Cell Lung (NSCLC) Clinical Trial
Locally Advanced NSCLC Hyperfractionated RT
Status: Enrolling, Phase II
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Simmons Comprehensive Cancer Center
345
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Status: Enrolling, Phase I
Updated: 12/31/1969
John Theurer Cancer Center at the Hackensack University Medical Center
1285
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Mcguire Va Medical Center
1110
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Phase 1 Study to Evaluate H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Phase 1 Study to Evaluate H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic, Jacksonville
1061
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Phase 1 Study to Evaluate H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials